Introduction
============

Increased consumption of omega-3 polyunsaturated fatty acids (ω3-PUFAs) from fish oil (FO) may exert beneficial effects on the heart, as evidenced by a decreased risk of ischemic heart disease, sudden cardiac death (Burr et al., [@B14]; GISSI-Prevenzione Investigators, [@B31]), and a lower incidence of heart failure (HF; Mozaffarian et al., [@B43]; Yamagishi et al., [@B67]; Levitan et al., [@B39]; Chen et al., [@B17]). Various mechanisms for the observed beneficial effects of ω3-PUFAs have been proposed, i.e., decrease in blood pressure, heart rate, and platelet aggregation, anti-inflammatory (Kris-Etherton et al., [@B37]), and ionic remodeling resulting in a decrease of cardiac arrhythmias (den Ruijter et al., [@B21]; London et al., [@B40]), but the exact mechanisms are not fully known.

Evidence is increasing that the Na^+^/H^+^-exchanger isoform-1 (NHE-1) plays a crucial role in ischemia/reperfusion injury, hypertrophy, and HF (for reviews, see Cingolani and Ennis, [@B19]; Fliegel, [@B28]; Vaughan-Jones et al., [@B59]). The NHE-1 is an integral membrane protein that extrudes one H^+^ ion in exchange for one Na^+^ ion in an electroneutral fashion. Its activity is high at acidic intracellular pH (pH~i~) conditions and gradually declines to zero when its set-point pH~i~ value, just above resting pH~i~ value (∼pH 7.2) is reached. At resting pH~i~ acid extrusion through NHE-1 activity equals acid loading activity and proton production rate, thereby maintaining pH~i~ at neutral values. This, however, is at the expense of a continuous Na^+^ influx. Thus, the NHE-1 has also a major role in intracellular Na^+^ (\[Na^+^\]~i~) loading (Baartscheer and van Borren, [@B8]; Fliegel, [@B28]; Vaughan-Jones et al., [@B59]). This \[Na^+^\]~i~ loading effect is of importance especially under conditions where NHE-1 activity is high such as ischemia/reperfusion (Ayoub et al., [@B3]; Bak and Ingwall, [@B9]; van Borren et al., [@B57]), hypertrophy, and HF (Baartscheer et al., [@B5]; Chahine et al., [@B16]; van Borren et al., [@B58]; Nakamura et al., [@B44]). In these conditions, the \[Na^+^\]~i~ loading via the NHE-1 shifts the driving force of Na^+^/Ca^2+^ exchange into the direction of less forward and increased reversed modes, which consequently will elevate intracellular Ca^2+^ (\[Ca^2+^\]~i~) concentration with potentially detrimental cardiac effects. Consequently, a reduction of Na^+^ influx via NHE-1 inhibition appears to be a promising pharmacological tool for the treatment of ischemia/reperfusion, hypertrophy, and HF (Baartscheer et al., [@B7]; Cingolani and Ennis, [@B19]).

Goel et al. ([@B32]) have shown that acute application of the ω3-PUFA eicosapentaenoic acid (EPA) as well as docosahexaenoic acid (DHA) inhibited the NHE-1 in isolated cardiomyocytes. Considering the importance of NHE-1 in ischemia/reperfusion injury, hypertrophy, and HF, NHE-1 inhibition may be the crucial link between FO and the well-known cardioprotective effects of ω3-PUFAs. In addition, it suggests that ω3-PUFAs may be an alternative or a complementary approach to existing NHE-1 inhibiting pharmacological drugs. In the present study we assessed the effects of long term treatment with ω3-PUFAs on NHE-1 in healthy rabbits and in a rabbit model of volume- and pressure-overload. To specifically address the effects of a diet rich in ω3-PUFAs from FO on NHE-1 in our study, we chose to use the ω9-MUFAs as a control fatty acids. These fatty are more abundantly present in the human diet and do not alter cardiac electrophysiology (den Ruijter et al., [@B22]). Therefore, rabbits were fed a diet rich in either ω3-PUFAs from FO or omega-9 monounsaturated fatty acids (ω9-MUFAs) from high-oleic sunflower oil (HOSF) as control.

Materials and Methods {#s1}
=====================

Animals and diet
----------------

All experiments were carried out in accordance with guidelines of the local institutional animal care and use committee. In addition, the investigation conforms the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).

Male New Zealand White rabbits (4 months old) received a diet (150 g/day; Research Diet Services, Wijk bij Duurstede, Netherlands) supplemented with either 1.25% (w/w) FO or 1.25% HOSF as control. Food consumption of every rabbit was measured and average food intake did not differ between FO and HOSF fed animals (data not shown). In the HF model, diet started 1 week before the surgical procedures to induce HF (see below). Lipids from the diet and the left ventricular tissue were extracted with the method of Folch et al. ([@B30]). Table [1](#T1){ref-type="table"} summarizes the fatty acid composition of these diets. In short, the total PUFA content was higher in the ω3-PUFAs diet due to a larger amount of both EPA and DHA.

###### 

**Fatty acid composition of ω9-MUFA and ω3-PUFA diets**.

                                    ω9-MUFA   ω3-PUFA
  --------------------------------- --------- ---------
  **SATURATED FATTY ACIDS**                   
  Total                             16.2      21.8
  **MONOUNSATURATED FATTY ACIDS**             
  Total                             44.0      17.9
  C18:1ω9 (oleic acid)              42.4      12.2
  **POLYUNSATURATED FATTY ACIDS**             
  Total                             37.6      56.6
  C18:2ω6 (LA*)*                    30.5      26.8
  C18:3ω3 (ALA)                     6.85      7.12
  C20:4ω6 (AA)                      0.00      0.57
  C20:5ω3 (EPA)                     0.1       9.2
  C22:6ω3 (DHA)                     0.1       6.3
  Other, unidentified fatty acids   2.2       3.6

*Fatty acid composition expressed as percentage of total fatty acids. ω9-MUFA, high-oleic sunflower oil; ω3-PUFA, fish oil; LA, linoleic acid; ALA, α-linolenic acid; AA, arachidonic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. The sum of listed components is less than the totals indicated here, since not all components were analyzed*.

Heart failure was induced by combined volume- and pressure-overload in two sequential surgical procedures as described previously in detail (Vermeulen et al., [@B66]; Baartscheer et al., [@B5]; Verkerk et al., [@B63]). In short, volume overload was produced by catheter-induced damage to the aortic valve until pulse pressure was increased by about 100%. Three weeks later, pressure-overload was created by abdominal aortic stenosis by ligation of approximately 50%. After 3 weeks for the healthy animals and after 4 months for the HF animals, the rabbits were anesthetized \[(ketamine (50 mg i.m.) and xylazine (10 mg i.m.)\], heparinized (5000 IU), and killed by intravenous injection of pentobarbital (240 mg).

Cell preparation
----------------

Single midmyocardial myocytes were isolated by enzymatic dissociation from the most apical part of the left ventricular free wall as described previously (de Groot et al., [@B20]). Small aliquots of cell suspension were put in a recording chamber on the stage of an inverted microscope. Myocytes were allowed to adhere for 5 min after which superfusion with Tyrode's solution was started. Tyrode's solution (36 ± 0.2°C) contained (in mM): NaCl 140, KCl 5.4, CaCl~2~ 1.8, MgCl~2~ 1.0, glucose 5.5, HEPES 5.0, pH 7.4 (NaOH). Quiescent rod-shaped cross-striated myocytes with a smooth surface were selected for measurements.

Intracellular pH measurements
-----------------------------

Intracellular pH (pH~i~) was measured in carboxy-seminaphthorhodafluor-1 (SNARF-AM, Molecular Probes) loaded myocytes as described previously (Baartscheer et al., [@B5]; van Borren et al., [@B57]). In short, myocytes were excited at 515 nm (75 W Xenon arc lamp) and dual wavelength emission of SNARF was recorded at wavelengths of 580 nm (*I*~580~) and 640 nm (*I*~640~). A rectangular adjustable slit ensured negligible background fluorescence levels. As shown in a typical example in Figure [1](#F1){ref-type="fig"}A, the *I*~580~/*I*~640~ ratio was calibrated by a series of precisely set pH solutions that contained 140 mM K^+^ instead of Na^+^ and the K^+^/H^+^ ionophore nigericin (10 μM; Sigma). Figure [1](#F1){ref-type="fig"}B shows the resulting calibration curve were the 580/640 ratios were plot against the pH~i~.

![**(A,B)** *In* *vivo* calibration curve of SNARF-AM. To determine calibration curve myocytes were loaded with SNARF-AM and superfused in presence op nigericin with several high K^+^ solutions at various pH~o~ values **(A)**. When the external and internal K^+^ free concentrations are equal, pH~i~ is the same as pH~o~. The calibration curve **(B)** was obtained by plotting the ratios (580/640) against the corresponding pH~o~. The red line represents a Henderson--Hasselbalch fit through these data, which revealed a maximum ratio of 2.97 and a minimum ratio of 0.36 and a p*K*~a~ of 7.57. **(C,D)** Determination of the intrinsic sarcoplasmic buffer power (β~i~). Typical example of the "stepwise reduction in extracellular NH~3~/NH~4~^+^ approach" in a myocyte isolated from a healthy, ω3-PUFA fed animal **(C)**, and pH~i~--β^i^ relationships of ω3-PUFA and ω9-MUFA myocytes of both healthy rabbits (Ctrl) and the rabbits with heart failure (HF). **(E)** Typical example and schematic explanation of an ammonium prepulse. **(F)** Typical examples of effects of Na^+^-free conditions and cariporide on the acid load recovery in HEPES-buffered conditions.](fphys-03-00076-g001){#F1}

### Intrinsic buffering power

In general, activities of acid loaders or extruders are expressed as the amount of acid or base extruded or loaded per second, the proton flux (*J*~H~; Roos and Boron, [@B52]). Changes in pH~i~ are not linearly related to *J*~H~ due to the presence of a pH~i~-dependent intrinsic sarcoplasmic buffer power (β~i~). β~i~ was determined by the "stepwise reduction in extracellular NH~3~/NH~4~^+^ approach" as described previously (Boyarsky et al., [@B13]), and shown in the typical example of Figure [1](#F1){ref-type="fig"}C. With each stepwise decrease in extracellular NH~3~/NH~4~^+^, the amount of protons delivered to the cytoplasm (Δ\[acid\]i) was considered equal to the resultant change in intracellular NH~4~^+^ concentration, which can be calculated from the observed pH~i~. ΔpH~i~ was taken as the change in pH~i~ produced by the stepwise decrease in extracellular NH~3~/NH~4~^+^. β~i~ was then calculated as −Δ\[acid\]~i~/ΔpH~i~ (Roos and Boron, [@B52]). β~i~ was assigned to the mean of the two pH~i~ values used for its calculation. Figure [1](#F1){ref-type="fig"}D shows the pH~i~--β~i~ relationships of myocytes isolated from ω3-PUFA and ω9-MUFA fed healthy rabbits and of myocytes of ω3-PUFA and ω9-MUFA fed rabbits with model of volume- and pressure-overload. The pH~i~--β~i~ relationships did not differ significantly, indicating that neither the diets nor HF affect the β~i~.

### NHE-1 activity

Na^+^/H^+^-exchanger isoform-1 activity was measured in HEPES-buffered conditions as recovery rate from acidosis due to ammonium prepulses as described previously (van Borren et al., [@B57]). Figure [1](#F1){ref-type="fig"}E shows a typical example and explanation of the pH changes in response to an ammonium prepulse. In short, 20 mM NH~4~Cl (NH~4~^+^/NH~3~) was rapidly added to the Tyrode's solution resulting instantly in alkalinization of myocytes (Figure [1](#F1){ref-type="fig"}E, phase 1), after which they slowly recovered from alkalization mainly because of NH~4~^+^ influx (Figure [1](#F1){ref-type="fig"}E, phase 2). After withdrawal of NH~4~^+^/NH~3~ from the extracellular solutions all intracellular NH~4~^+^ is converted to NH~3~ which leaves the myocyte and the remaining H^+^ acidifies the sarcoplasm (Figure [1](#F1){ref-type="fig"}E, phase 3). Subsequently, in HEPES-buffered solutions, the myocytes slowly recovered from the acid load due to NHE-1 activity (Figure [1](#F1){ref-type="fig"}E, phase 4). The recovery from acid load is Na^+^-dependent as well as blocked by cariporide (10 μM; Figure [1](#F1){ref-type="fig"}F), typical hallmarks of the NHE-1. From the pH~i~ traces we computed the dpH~i~/dt's and multiplied these with β~i~ to arrive at *J*~NHE-1~.

Cellular electrophysiology
--------------------------

Action potentials (APs) and delayed afterdepolarizations (DADs) were recorded with the perforated patch-clamp technique using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA, USA). Signals were low-pass filtered with a cut-off frequency of 2 kHz and digitized at 3 kHz. Data acquisition and analysis were accomplished using custom software and potentials were corrected for liquid junction potential (Barry and Lynch, [@B10]). APs were elicited at 3 Hz by 3-ms long, 1.2× threshold current pulses through the patch pipette. We analyzed resting membrane potential (RMP), maximal upstroke velocity (*V*~max~), AP amplitude (APA), and AP duration at 20, 50, and 90% repolarization (APD~20~, APD~50~, and APD~90~, respectively). Susceptibility to DADs were evoked by a 3-Hz (10-s) rapid pacing episode followed by an 8-s pause (tracing period) in the presence of norepinephrine (100 nM, Centrafarm, Etten-Leur, The Netherlands). A DAD was defined as a temporary, short-lived deviation from (an otherwise stable) RMP of more than 2 mV. Data from five APs and five rapid pacing episode were averaged. Cell membrane capacitance, an electrophysiological measure of cell size, was estimated as we described previously in detail (Verkerk et al., [@B61]).

Statistics
----------

Data are mean ± SEM. Groups were compared using Two-Way Repeated Measures ANOVA followed by pairwise comparison using the Student--Newman--Keuls test, Fisher's exact test, or unpaired *t*-test. *P* \< 0.05 is considered statistical significant.

Results
=======

ω3-PUFA rich diet results in ω3-PUFAs incorporated in the cell membrane
-----------------------------------------------------------------------

The diet rich in ω3-PUFAs from FO resulted in a significant increase of ω3-PUFAs EPA and DHA of the total amount of fatty acids extracted from the heart of both healthy and HF rabbits (Table [2](#T2){ref-type="table"}). The total amount of monounsaturated fatty acids, however, was significantly lower in the ω3-PUFAs fed rabbit hearts compared to the ω9-MUFAs fed rabbit hearts. Thus, ω3-PUFAs from the diet were incorporated in the cell membrane at the expense of monounsaturated fatty acids.

###### 

**Phospholipid composition of the heart (% of total fat extracted)**.

                                    Healthy rabbits   HF rabbits                
  --------------------------------- ----------------- ------------- ----------- -------------
  **SATURATED FATTY ACIDS**                                                     
  Total                             29 ± 3            29 ± 1        23 ± 1      25 ± 1
  **MONOUNSATURATED FATTY ACIDS**                                               
  Total                             31 ± 4            22 ± 2\*      23 ± 2      17 ± 1\*
  C18:1ω9 (oleic acid)              26 ± 4            17 ± 2\*      19 ± 2      13 ± 1\*
  **POLYUNSATURATED FATTY ACIDS**                                               
  Total                             38 ± 6            47 ± 3        47 ± 1      51 ± 1\*
  C18:2ω6 (LA*)*                    28 ± 3            28 ± 1        32 ± 1      30 ± 1
  C18:3ω3 (ALA)                     3.8 ± 0.8         4.0 ± 0.6     2.8 ± 0.5   3.2 ± 0.4
  C20:4ω6 (AA)                      4.7 ± 3.2         4.6 ± 1.5     8.9 ± 1.2   5.7 ± 0.6
  C20:5ω3 (EPA)                     0.1 ± 0.1         3.4 ± 1\*     0.1 ± 0.1   3.9 ± 0.3\*
  C22:6ω3 (DHA)                     0.3 ± 0.2         4.7 ± 1.4\*   0.8 ± 0.2   6.4 ± 0.5\*
  Unidentified fatty acids          1.4 ± 0.6         1.4 ± 0.3     7.4 ± 1.1   7.2 ± 0.9

*Fatty acid composition expressed as percentage of total fatty acids. ω9-MUFA, high-oleic sunflower oil; ω3-PUFA, fish oil; LA, linoleic acid; ALA, α-linolenic acid; AA, arachidonic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. The sum of listed components is less than the totals indicated here, since not all components were analyzed. \**P* \< 0.05 ω9-MUFA vs. 3-PUFA diet*.

Dietary ω3-PUFAs do not affect NHE-1 activity in healthy rabbits
----------------------------------------------------------------

In a first series of experiments, we measured the NHE-1 in myocytes isolated from healthy rabbits. Body weight after 3 weeks of diet was similar in ω3-PUFA and ω9-MUFA fed animals (3.1 ± 0.2, *n* = 9) vs. 2.9 ± 0.2 kg (*n* = 7), *P* \> 0.05). Figure [2](#F2){ref-type="fig"}A, top panel, shows representative recordings of the pH~i~ recovery after an ammonium prepulse (see [Materials and Methods](#s1){ref-type="sec"}) in a myocyte isolated from an ω3-PUFA and ω9-MUFA fed rabbit. The pH~i~ recovery, and consequently the calculated *J*~NHE-1~ (Figure [2](#F2){ref-type="fig"}A, bottom panel), was virtually overlapping in the myocytes of ω3-PUFA and ω9-MUFA fed animals. Figure [2](#F2){ref-type="fig"}B shows the average *J*~NHE-1~ in the myocytes of ω3-PUFA ω9-MUFA fed animals. The average *J*~NHE-1~ was not significantly different in the myocytes of ω3-PUFA and ω9-MUFA fed animals at any of the pH~i~'s.

![**(A)** Typical examples of pH~i~ recovery after an ammonium prepulse (top) and the calculated *J*~NHE-1~ (bottom) in an ω9-MUFA and ω3-PUFA myocyte isolated from healthy animals. **(B)** Average *J*~NHE-1~ in myocytes of ω9-MUFA and ω3-PUFA fed healthy animals.](fphys-03-00076-g002){#F2}

Dietary ω3-PUFAs reduces the NHE-1 activity in a rabbit model of volume- and pressure-overload
----------------------------------------------------------------------------------------------

In a second series of experiments, we studied the NHE-1 activity in myocytes isolated from rabbits that underwent model of volume- and pressure-overload for 4 months. Figure [3](#F3){ref-type="fig"}A, top panel, shows representative of the pH~i~ recovery after an ammonium prepulse in a myocyte of an ω3-PUFA and ω9-MUFA fed animal. In the HF rabbits, pH~i~ recovery after an ammonium prepulse was slower in the myocyte of the ω3-PUFA animal compared to that in the myocyte of the ω9-MUFA fed animal. Consequently, the calculated *J*~NHE-1~ was lower in the myocyte of the ω3-PUFA rabbit (Figure [3](#F3){ref-type="fig"}A, bottom panel). Figure [3](#F3){ref-type="fig"}B shows the average *J*~NHE-1~ in myocytes of ω3-PUFA and ω9-MUFA fed HF animals. The average *J*~NHE-1~ was significantly lower in myocytes of ω3-PUFA animals at pH values lower than 7.1 (*P* \< 0.05).

![**(A)** Typical examples of pH~i~ recovery after an ammonium prepulse (top) and the calculated *J*~NHE-1~ (bottom) in an ω9-MUFA and ω3-PUFA myocyte isolated from rabbit which underwent volume- and pressure-overload. **(B)** Average *J*~NHE-1~ in myocytes isolated from ω9-MUFA and ω3-PUFA fed rabbits with volume- and pressure-overload. \**P* \< 0.05.](fphys-03-00076-g003){#F3}

Dietary ω3-PUFAs oppose the increase in NHE-1 activity induced by heart failure
-------------------------------------------------------------------------------

In HF animals, but not in healthy animals, NHE-1 activity in ω3-PUFAs myocytes was significantly lower than in ω9-MUFAs myocytes (Figures [2](#F2){ref-type="fig"}B and [3](#F3){ref-type="fig"}B). Previous studies demonstrate that the NHE-1 activity is significantly increased in animal and patients with HF (Baartscheer et al., [@B5]; Chahine et al., [@B16]; van Borren et al., [@B58]). This suggests that dietary ω3-PUFAs suppress the increase in NHE-1 activity in our rabbit HF model. Figure [4](#F4){ref-type="fig"} shows the averages *J*~NHE-1~ at pH 7.0 of myocytes of ω3-PUFA and ω9-MUFA fed healthy and HF animals. HF significantly increased the *J*~NHE-1~ in myocytes of ω9-MUFA fed animals (*P* \< 0.05), but not in myocytes of ω3-PUFA fed animals. Thus, a diet rich in ω3-PUFAs suppresses the increase in NHE-1 activity associated with HF.

![**Average *J*~NHE-1~ at pH = 7.0 of healthy (Ctrl) and HF rabbits fed ω9-MUFA and ω3-PUFA rich diets**. Note that *J*~NHE-1~ is increased in the HF model in ω9-MUFA fed animals, while it was not changed in ω3-PUFA animals. \**P* \< 0.05.](fphys-03-00076-g004){#F4}

Dietary ω3-PUFAs reduces the incidence of DADs in a rabbit model of volume- and pressure-overload
-------------------------------------------------------------------------------------------------

Volume- and pressure-overload in rabbit increased the NHE-1 activity resulting in elevated \[Na^+^\]~i~ and secondarily to increased \[Ca^2+^\]~i~ (Baartscheer et al., [@B5]). The altered Ca^2+^ handling in HF is associated with spontaneous Ca^2+^ release from the sarcoplasmic reticulum (SR; Baartscheer et al., [@B6]), which activate the transient inward current, *I*ti, resulting in DADs (Verkerk et al., [@B64]). ω3-PUFAs, and not ω9-MUFA, suppress the increase in NHE-1 activity in our rabbit model of volume- and pressure-overload. Thus, we hypothesized that the incidence of DADs is lower in myocytes of ω3-PUFAs fed HF rabbits compared to those of ω9-MUFA fed HF rabbits. Next, we tested the susceptibility to induced DADs in HF myocytes by rapid pacing in the presence of 100 nM noradrenalin.

Figure [5](#F5){ref-type="fig"}A shows typical examples of APs and DAD of myocytes isolated from an ω3-PUFA and an ω9-MUFA fed HF animal. In the myocyte of the ω9-MUFA fed HF rabbit, but not in the myocyte of the ω3-PUFA fed HF rabbit, a DAD (arrow) was present. The amount of myocytes with more than one DAD was significantly lower (*P* \< 0.05, Fisher's exact test) in ω3-PUFA fed HF rabbits compared to those of ω9-MUFA fed HF animal (Table [3](#T3){ref-type="table"}). In addition, the number of DADs was significantly lower in the myocytes of ω3-PUFA fed HF rabbits (Figure [5](#F5){ref-type="fig"}B). Figure [5](#F5){ref-type="fig"}C summarizes the average AP characteristics at 3 Hz of myocytes isolated from ω3-PUFA and an ω9-MUFA fed HF animal in the presence of 100 nM noradrenaline. In presences of 100 nM noradrenaline, no AP differences were observed between myocytes of ω3-PUFA and an ω9-MUFA fed HF animal.

###### 

**Susceptibility to induce delayed afterdepolarizations (DADs)**.

            Fewer than 1 DAD   1 or more DAD
  --------- ------------------ ---------------
  ω9-MUFA   2                  12
  ω3-PUFA   7                  5

*Number of myocytes. Values indicate the number of myocytes having \<1 or ≥1 DAD (average of five tracings). The susceptibility to induce DADs is significantly lower in ω3-PUFA compared to ω9-MUFA myocytes (*P* \< 0.05, Fisher's exact test)*.

![**(A)** Typical examples of action potentials (AP) and delayed afterdepolarizations (DADs, arrow). **(B)** Average number of DADs, **(C)** Average AP characteristics. RMP, resting membrane potential; APA, AP amplitude; dV/dt~max~, maximal AP upstroke velocity; APD~20~, APD~50~, and, APD~90~, AP duration at 20, 50, and 90% repolarization, respectively, \**P* \< 0.05.](fphys-03-00076-g005){#F5}

Hypertrophy is similar in ω3-PUFAs and ω9-MUFAs fed rabbits
-----------------------------------------------------------

Various studies demonstrate that ω3-PUFAs suppress development of hypertrophy and HF (Takahashi et al., [@B56]; Duda et al., [@B26]; Ramadeen et al., [@B51]; Chen et al., [@B17]). Because cardiac hypertrophy leads to a decrease of the surface to volume ratio of myocytes, an increased number of NHE-1 proteins are required to maintain a normal "cytoplasmic" NHE-1 mediated acid load recovery. The maintained cytoplasmic NHE-1 activity observed in cardiomyocytes from ω3-PUFAs treated HF rabbits (Figure [4](#F4){ref-type="fig"}) may thus be explained also by a lower degree of hypertrophy. Therefore, we finally analyzed important parameters for hypertrophy and HF in ω3-PUFA and ω9-MUFA fed rabbits, which underwent volume- and pressure-overload. Body, lung, and heart weight were similar in ω3-PUFA and ω9-MUFA rabbits (Figure [6](#F6){ref-type="fig"}A). Consequently, relative lung weight and relative heart weight, an index of cardiac hypertrophy, were not significantly different (Figure [6](#F6){ref-type="fig"}B). While previously we observed relative heart weights of 2.2--2.5 in non-failing rabbits with a standard chow diet (Baartscheer et al., [@B5],[@B6], [@B7], [@B4]; de Groot et al., [@B20]; van Borren et al., [@B58]), the relative heart weights in the present study of ω3-PUFA and ω9-MUFA fed rabbits were 3.6 ± 0.26 and 3.3 ± 1.13, respectively. Thus, despite the absence of differences in degree of hypertrophy, both ω3-PUFA and ω9-MUFA fed HF rabbit hearts are equally hypertrophied. Moreover, cell capacitance, an electrophysiological measure of cell size, was not significantly different between myocytes of ω3-PUFA and ω9-MUFA rabbits (Figure [6](#F6){ref-type="fig"}C). Furthermore, the presence of ascites assessed at autopsy was the same in ω3-PUFA and ω9-MUFA rabbits. These data indicate that the degree of hypertrophy and HF are similar in ω3-PUFA and ω9-MUFA fed rabbits.

![**(A)** Average body, lung, and heart weight in ω3-PUFA and ω9-MUFA fed rabbits which underwent volume- and pressure-overload. *n*, Number of rabbits **(B)**, Relative lung weight and relative heart weight, an index of cardiac hypertrophy, in ω3-PUFA, and ω9-MUFA fed rabbits which underwent volume- and pressure-overload. **(C)** Average cell membrane capacitance of myocytes isolated from ω3-PUFA and ω9-MUFA rabbits. *n*, Number of myocytes. \**P* \< 0.05.](fphys-03-00076-g006){#F6}

Discussion
==========

Overview
--------

In this study we examined the effects of dietary ω3-PUFAs on NHE-1 of myocytes from healthy and failing hearts. In general, NHE-1 inhibition is thought to be a pharmacological tool for the treatment of various detrimental cardiac conditions such as ischemia/reperfusion injury, arrhythmias, hypertrophy, and HF. In many pre-clinical studies, NHE-1 inhibition has been shown to reduce ischemia/reperfusion injury (Lee et al., [@B38]; Ayoub et al., [@B2]). In clinical trials, however, the cardioprotective effects of NHE-1 inhibition were less clear and the treatment with the NHE-1 inhibitor cariporide was associated with significantly greater incidence of stroke (Fliegel and Karmazyn, [@B29]). These adverse effects halted the further use of cariporide as cardioprotective agent.

Cardiac NHE-1 activity is also significantly increased in animal and patients with HF (Baartscheer et al., [@B5]; Chahine et al., [@B16]). Pre-clinical studies demonstrated that chronic inhibition of NHE-1 leads to reversal of cardiac fibrosis, hypertrophy and HF, and improved contractility in HF models in mice (Engelhardt et al., [@B27]), rats (Camillión de Hurtado et al., [@B15]; Chen et al., [@B18]), and rabbit (Baartscheer et al., [@B7], [@B4]). In rabbit studies, a diet containing the NHE-1 inhibitor cariporide not only reversed hypertrophy and reduced signs of HF, but also reversed cardiac ionic and electrical remodeling and prevented changes in myocyte dimensions, AP duration, and NHE-1 fluxes (Baartscheer et al., [@B7], [@B4]). In addition, Ca^2+^ homeostasis remained undisturbed, and no increase of the incidence of Ca^2+^ after transient dependent DADs occurred (Baartscheer et al., [@B7]). From the prevention of excessive fibrosis, prolongation of AP duration, and DADs (Nuss et al., [@B46]; Marx et al., [@B41]; Sipido et al., [@B55]; Janse, [@B34]; Pogwizd and Bers, [@B50]), one may infer that NHE-1 inhibition is also anti-arrhythmic. Thus, at least part of the beneficial effects of ω3-PUFAs may be attributed to NHE-1 inhibition during HF.

Dietary ω3-PUFAs do not suppress the NHE-1 in myocytes of healthy animals
-------------------------------------------------------------------------

In myocytes isolated from healthy animals, we found that ω3-PUFAs do not affect the NHE-1 activity as compared to ω9-MUFAs (Figure [2](#F2){ref-type="fig"}). Our results contrast with a study by Goel et al. ([@B32]) that showed that ω3-PUFAs reduced the NHE-1 activity. This discrepancy is likely due to study design. We studied dietary ω3-PUFAs intake that causes ω3-PUFA incorporation into cardiac cell membranes (Owen et al., [@B49]), whereas Goel et al. ([@B32]) studied direct application of ω3-PUFAs on cardiac myocytes. Acutely applied ω3-PUFAs and incorporated ω3-PUFAs have different effects on cardiac electrophysiology (den Ruijter et al., [@B21], [@B24]; Verkerk et al., [@B60]), and our study suggests that it also has a different effect on pH~i~. Dietary ω3-PUFAs intake does not affect the resting pH~i~ in healthy animals (present study), while acute administration resulted in acidosis (Aires et al., [@B1]), which could well explain the lower apparent NHE-1 activity observed by Goel et al. Other explanations may be the differences in species (pig vs. rabbit) and the technique used to measure NHE-1 activity (radioactive Na^+^ uptake in cell suspensions vs. single cell fluorescence).

Dietary ω3-PUFAs suppress NHE-1 upregulation in a rabbit model of volume- and pressure-overload
-----------------------------------------------------------------------------------------------

In our rabbit model of volume- and pressure-overload, we found that the NHE-1 activity in ω3-PUFAs myocytes was significantly lower than in ω9-MUFAs myocytes (Figure [3](#F3){ref-type="fig"}). The mechanisms for the lower NHE-1 activity are unknown. One may speculate that ω3-PUFAs affect membrane fluidity (Jahangiri et al., [@B33]), resulting in a decrease of NHE-1 activity (Bookstein et al., [@B12]). This membrane fluidity theory is frequently used to explain the effects of ω3-PUFAs on membrane channels, however, but the lack of significant effects of ω3-PUFAs on NHE-1 in healthy animals is not in line of this hypothesis.

A second hypothesis is that ω3-PUFAs attenuate cardiac hypertrophy (Takahashi et al., [@B56]; Duda et al., [@B26]; Ramadeen et al., [@B51]; Chen et al., [@B17]), resulting in a decrease of NHE-1 activity (Baartscheer et al., [@B7]). In the present study, however, the relative heart weight and cell capacitance, both indices of cardiac hypertrophy, did not differ between ω3-PUFAs and ω9-MUFAs fed rabbits or their myocytes, respectively (Figure [6](#F6){ref-type="fig"}). This excludes differences in hypertrophy as a likely mechanism. The unaltered degree of hypertrophy is in contrast with observations in mice with transverse aortic constriction (Chen et al., [@B17]) and juvenile visceral steatosis (Takahashi et al., [@B56]), rats with abdominal aortic banding (Duda et al., [@B26]), and rapid-paced dogs (Ramadeen et al., [@B51]) where dietary supplementation of ω3-PUFAs attenuated cardiac hypertrophy. This discrepancy may be explained by differences in HF model, species, ω3-PUFAs concentration, but also to the control diets used. In our study, the control (ω9-MUFAs) diet was supplemented with HOSF, while in the other studies the control diet was standard chow or supplemented with corn oil. The importance of a proper control diet is supported by the finding that the relative heart weight of ω9-MUFAs fed HF rabbits was ≈3.6 (Figure [6](#F6){ref-type="fig"}), while in the same rabbit HF model with a standard chow diet we previously measured relative heart weights of 4.4--6.0 in our laboratory (Baartscheer et al., [@B5],[@B6], [@B7], [@B4]; de Groot et al., [@B20]; van Borren et al., [@B58]; den Ruijter et al., [@B22]). This suggests that both ω3-PUFAs and ω9-MUFAs diets reduce the degree of hypertrophy. Further studies are required to address this.

A third hypothesis is that dietary ω3-PUFAs affect cell signaling and enzymes important for NHE-1 activity. The NHE is not only activated by pH~i~ but also by a number of other stimuli. NHE-1 activity is accelerated in response of endothelin, angiotensin II, and G protein and second messenger stimulation of PKC (diacylglycerol) and PKA (forskolin, β1-adrenoreceptor agonists; Kandasamy et al., [@B35]; Karmazyn et al., [@B36]; Díaz et al., [@B25]). Also, mitogen-activated protein (MAP) kinase-dependent pathways result in the phosphorylation of the NHE (Sartori et al., [@B53]). ω3-PUFAs affect several of these NHE-1 stimuli. They reduce diacylglycerol and PKC, activate the parasympathetic nervous system, and reduce angiotensin-converting enzyme (ACE) activity (Mohan and Das, [@B42]; Seung-Kim et al., [@B54]; Takahashi et al., [@B56]), although the latter is not a consistent finding (Ogawa et al., [@B47]). An intriguing question is why the NHE-1 activity in myocytes of ω3-PUFA fed animals is lower than in myocytes of ω9-MUFA fed animals in our model of volume- and pressure-overload, while it is not different in healthy rabbits. This suggests that the NHE-1 reduction is due to changes in cell signaling pathways active during HF (Onohara et al., [@B48]; Niizeki et al., [@B45]). One can speculate that the lower NHE-1 activity also reduces the degree of hypertrophy and HF, but this was not observed in the present study, suggesting that NHE-1 is more sensitive for ω3-PUFAs modulation of cellular signaling pathways than hypertrophy and HF. Alternatively, the time required for hypertrophy and HF attenuation might be longer than that for NHE-1 reduction. The decreased NHE-1 activity may also be the result of a decreased expression of NHE-1.

Dietary ω3-PUFAs suppress DADs
------------------------------

In our HF model of volume-and pressure-overload, we observed that the susceptibility for DAD development was significantly lower in myocytes of ω3-PUFAs fed rabbits compared to those of ω9-MUFAs fed rabbits (Table [3](#T3){ref-type="table"}; Figure [6](#F6){ref-type="fig"}B). DADs occur in \[Ca^2+^\]~i~ overload condition (Verkerk et al., [@B64], and primary references cited therein). Thus, our results indicate that myocytes of ω3-PUFAs fed failing rabbits are less sensitive for \[Ca^2+^\]~i~ overload development than those of ω 9-MUFAs fed failing rabbits. According to the importance of the NHE-1 for \[Ca^2+^\]~i~ (Baartscheer et al., [@B5]), it is tempting to speculate that this is due to the lower NHE-1 activity in myocytes of ω3-PUFAs fed HF rabbits. Previously we observed multiple changes in ionic currents due to dietary and acute ω3-PUFAs resulting in AP shortening (Verkerk et al., [@B62]) and reduced susceptibility of early afterdepolarizations and DADs development (den Ruijter et al., [@B23], [@B22]; Berecki et al., [@B11]).

Dietary ω3-PUFAs caused an increase of *I*~K1~ resulting in a more stable RMP (Verkerk et al., [@B62]). The latter will result in smaller DAD amplitudes. In addition, dietary ω3-PUFAs decreased *I*~NCX~ (Verkerk et al., [@B62]), which carries the transient inward current, *I*~ti~, responsible for DADs (Verkerk et al., [@B64], and primary references cited therein). Decreased *I*~NCX~ may therefore also result in DADs of smaller amplitude. However, while both changes may reduce the DAD amplitude, they will not reduce the propensity to spontaneous Ca^2+^ release of the SR and thus DADs. Previously, we observed AP shortening due to dietary ω3-PUFAs (Verkerk et al., [@B62]). AP shortening leads to an increased diastolic interval, favoring removal of excess Ca^2+^ from the cytosol. This will reduce \[Ca^2+^\]~i~ overload conditions and DAD occurrence (Verkerk et al., [@B65], and primary refs. cited therein). However, in presence of 100 nM noradrenaline, AP duration did not differed significantly between myocytes of ω3-PUFAs and ω9-MUFAs fed HF rabbits (Figure [5](#F5){ref-type="fig"}C). Thus, in the present study the role of AP duration in susceptibility of DADs is limited, although this cannot be entirely excluded in the absence of data on intracellular calcium and sodium activity.

Conclusion
==========

Dietary ω3-PUFAs from FO suppress upregulation of the NHE-1 activity in a rabbit model of volume- and pressure-overload. The degree of hypertrophy and HF is similar in myocytes of ω3-PUFAs and ω9-MUFAs fed HF rabbits, but the lower NHE-1 activity in myocytes of ω3-PUFAs fed HF rabbits suggests that dietary ω3-PUFAs administration during the development of HF may be anti-arrhythmic via reduction of ischemia/reperfusion injury and Ca^2+^-modulated arrhythmias.
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